Larvol Delta - Influence-of-a-threemonth-letermovir-treatment-on-inflammation-immunity-and-HIV-reservoir-markers-in-people-with-HIV-on-antiretroviral-therapy

Prevymis (letermovir) - Merck (MSD)

https://www.escmid.org/congress-events/escmid-global/programme/preliminary-programme/

Léna ROYSTON

Mar 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next